NKG2A/CD94 Is a New Immune Receptor for HLA-G and Distinguishes Amino Acid Differences in the HLA-G Heavy Chain

Natural killer (NK) cell therapies are a tool to antagonize a dysfunctional immune system. NK cells recognize malignant cells, traffic to a tumor location, and infiltrate the solid tumor. The immune checkpoint molecule human leukocyte antigen (HLA)-G is upregulated on malignant cells but not on heal...

Descripción completa

Detalles Bibliográficos
Autores principales: Hò, Gia-Gia T., Celik, Alexander A., Huyton, Trevor, Hiemisch, Wiebke, Blasczyk, Rainer, Simper, Gwendolin S., Bade-Doeding, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352787/
https://www.ncbi.nlm.nih.gov/pubmed/32575403
http://dx.doi.org/10.3390/ijms21124362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352787/
https://www.ncbi.nlm.nih.gov/pubmed/32575403
http://dx.doi.org/10.3390/ijms21124362

Ejemplares similares